Ravi Potluri

Use of a claims database to characterize and estimate the incidence rate for Castleman disease

Nikhil C. Munshi, Maneesha Mehra, Helgi van de Velde et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 165 citations

Medicine, Internal Medicine, Pathology +15

Characterization of Treatment Resistant Depression Episodes in a Cohort of Patients from a US Commercial Claims Database

N Kubitz, Maneesha Mehra, Ravi Potluri et al. · PLoS ONE · 2013 · 148 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Analysis of Real-World Data on Overall Survival in Multiple Myeloma Patients With ≥3 Prior Lines of Therapy Including a Proteasome Inhibitor (PI) and an Immunomodulatory Drug (IMiD), or Double Refractory to a PI and an IMiD

Saad Z. Usmani, Tahamtan Ahmadi, Yvette Ng et al. · The Oncologist · 2016 · 140 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma

Rafaël Fonseca, Saad Z. Usmani, Maneesha Mehra et al. · BMC Cancer · 2020 · 123 citations · Full text

Medicine, Oncology, Cell Therapy +12

Treatment evolution for metastatic castration‐resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real‐world data

Thomas W. Flaig, Ravi Potluri, Yvette Ng et al. · Cancer Medicine · 2015 · 61 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16